SCHEMBL3558167

SCHEMBL3558167

O=C(NCc1cccnc1)c1ccc2n1Cc1ccccc1N(C(=O)c1c(F)cccc1F)C2

nearest known ligand 0.48

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 1/20 0.44
ALDH1A1 P00352 1/20 0.42
USP2 O75604 1/20 0.41
LMNA P02545 2/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
KDM4E B2RXH2 2/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
GAA P10253 1/20 0.41
VNN1 O95497 1/20 0.41
NAMPT P43490 1/20 0.41
THRB P10828 1/20 0.41
HTT P42858 1/20 0.39
TLR2 O60603 1/20 0.39
TSHR P16473 1/20 0.39
MAPK10 P53779 1/20 0.39
HSD17B10 Q99714 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3550441 0.91 USP2 (0.46) NPSR1ALDH1A1USP2LMNASMN1; SMN2
SCHEMBL3556652 0.90 KMT2A (0.46) NPSR1ALDH1A1USP2LMNASMN1; SMN2
SCHEMBL3555310 0.90 NAMPT (0.44) NPSR1ALDH1A1USP2LMNASMN1; SMN2
SCHEMBL3557245 0.89 NAMPT (0.47) NPSR1USP2LMNASMN1; SMN2GAA
SCHEMBL3556774 0.88 VNN1 (0.46) NPSR1ALDH1A1USP2LMNASMN1; SMN2
SCHEMBL3554440 0.88 USP2 (0.47) ALDH1A1USP2LMNASMN1; SMN2KDM4E
SCHEMBL3550414 0.88 STAT3 (0.48) ALDH1A1USP2LMNASMN1; SMN2KDM4E
SCHEMBL3550048 0.87 VNN1 (0.47) ALDH1A1USP2LMNASMN1; SMN2KDM4E
SCHEMBL3553322 0.85 POLB (0.48) ALDH1A1USP2LMNASMN1; SMN2KDM4E
SCHEMBL3553868 0.85 POLB (0.48) NPSR1ALDH1A1USP2LMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7678787-B2 Pyrrolobenzodiazepine pyridine carboxamides and derivatives as follicle-stimulating hormone receptor antagonists WYETH (US) 2010-03-16 US claimed
EP-1893615-A1 PYRROLOBENZODIAZEPINE PYRIDINE CARBOXAMIDES AND DERIVATIVES AS FOLLICLE-STIMULATING HORMONE RECEPTOR ANTAGONISTS Wyeth a Corporation of the State of Delaware (US) 2008-03-05 EP claimed
US-20060287522-A1 Pyrrolobenzodiazepine pyridine carboxamides and derivatives as follicle-stimulating hormone receptor antagonists WYETH (US) 2006-12-21 US claimed
WO-2006135687-A1 PYRROLOBENZODIAZEPINE PYRIDINE CARBOXAMIDES AND DERIVATIVES AS FOLLICLE-STIMULATING HORMONE RECEPTOR ANTAGONISTS WYETH (US) 2006-12-21 WO claimed
US-7678787-B2 Pyrrolobenzodiazepine pyridine carboxamides and derivatives as follicle-stimulating hormone receptor antagonists WYETH (US) 2010-03-16 US disclosed
US-20060287522-A1 Pyrrolobenzodiazepine pyridine carboxamides and derivatives as follicle-stimulating hormone receptor antagonists WYETH (US) 2006-12-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060287522-A1 Pyrrolobenzodiazepine pyridine carboxamides and derivatives as follicle-stimulating hormone receptor antagonists FSHR, GNRHR, PRLHR NPSR1 21/4885ALDH1A1 4219/4885USP2 2723/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.